Cargando…

Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome

The purpose of this study was to evaluate the correlation between severity of obstructive sleep apnoea syndrome (OSAS), cardiovascular disease and metabolic syndrome. We recruited 1185 patients with OSAS who underwent a complete ENT examination, including nasolaryngeal fibre optic endoscopy with Mül...

Descripción completa

Detalles Bibliográficos
Autores principales: FUSETTI, M., FIORETTI, A.B., VALENTI, M., MASEDU, F., LAURIELLO, M., PAGLIARELLA, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546405/
https://www.ncbi.nlm.nih.gov/pubmed/23326012
_version_ 1782256049880825856
author FUSETTI, M.
FIORETTI, A.B.
VALENTI, M.
MASEDU, F.
LAURIELLO, M.
PAGLIARELLA, M.
author_facet FUSETTI, M.
FIORETTI, A.B.
VALENTI, M.
MASEDU, F.
LAURIELLO, M.
PAGLIARELLA, M.
author_sort FUSETTI, M.
collection PubMed
description The purpose of this study was to evaluate the correlation between severity of obstructive sleep apnoea syndrome (OSAS), cardiovascular disease and metabolic syndrome. We recruited 1185 patients with OSAS who underwent a complete ENT examination, including nasolaryngeal fibre optic endoscopy with Müller's manoeuvre, overnight cardio-respiratory monitoring, Epworth Sleepiness Scale (ESS) to measure daytime sleepiness, body mass index (BMI), measurement of blood pressure and blood tests. Subsequently, subjects were divided into three subgroups according to the Apnoea Hypopnoea Index (AHI): mild OSAS (AHI 5-15), moderate OSAS (AHI 15-30) and severe OSAS (AHI > 30). In the sample collected, 347 (262 males and 85 females) of 1185 patients suffered from mild OSAS, 363 (269 males and 94 females) from moderate OSAS and 475 (330 males and 145 females) from severe OSAS. In the group suffering from mild OSAS, we found: 127 patients affected by hypertension, 48 with diabetes, 11 with dyslipidaemia and 32 with metabolic syndrome. In the group with moderate OSAS there were 157 patients with hypertension, 63 with diabetes, 72 with dyslipidaemia and 47 with metabolic syndrome. In the group suffering from severe OSAS there were 244 patients with hypertension, 138 with diabetes, 47 with dyslipidaemia and 90 with metabolic syndrome. For data analysis, we used the Spearman correlation test adjusted according to Sidak between the dependent variable AHI and the independent variables BMI, ESS, average SO2 (SO(2med)), hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome. The results show different patterns of correlation in terms of statistical significance: BMI ρ(s) = 0.26, SO(2med) ρ(s) = -0:51, hypertension ρ(s) = -0.05, dyslipidaemia ρ(s) = 0.22 for women, and BMI ρ(s) = 0.53, ESS ρ(s) = 0.28, SO(2med) ρ(s) = -0.50, hypertension ρ(s) = 0.17, diabetes mellitus ρ(s) = 0.28 and metabolic syndrome ρ(s) = 0.26 for men. The results of the study confirm the existence of a statistically significant correlation between the severity of OSAS and BMI, ESS, average SO2, hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome.
format Online
Article
Text
id pubmed-3546405
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Pacini Editore SpA
record_format MEDLINE/PubMed
spelling pubmed-35464052013-01-16 Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome FUSETTI, M. FIORETTI, A.B. VALENTI, M. MASEDU, F. LAURIELLO, M. PAGLIARELLA, M. Acta Otorhinolaryngol Ital Sleep Medicine The purpose of this study was to evaluate the correlation between severity of obstructive sleep apnoea syndrome (OSAS), cardiovascular disease and metabolic syndrome. We recruited 1185 patients with OSAS who underwent a complete ENT examination, including nasolaryngeal fibre optic endoscopy with Müller's manoeuvre, overnight cardio-respiratory monitoring, Epworth Sleepiness Scale (ESS) to measure daytime sleepiness, body mass index (BMI), measurement of blood pressure and blood tests. Subsequently, subjects were divided into three subgroups according to the Apnoea Hypopnoea Index (AHI): mild OSAS (AHI 5-15), moderate OSAS (AHI 15-30) and severe OSAS (AHI > 30). In the sample collected, 347 (262 males and 85 females) of 1185 patients suffered from mild OSAS, 363 (269 males and 94 females) from moderate OSAS and 475 (330 males and 145 females) from severe OSAS. In the group suffering from mild OSAS, we found: 127 patients affected by hypertension, 48 with diabetes, 11 with dyslipidaemia and 32 with metabolic syndrome. In the group with moderate OSAS there were 157 patients with hypertension, 63 with diabetes, 72 with dyslipidaemia and 47 with metabolic syndrome. In the group suffering from severe OSAS there were 244 patients with hypertension, 138 with diabetes, 47 with dyslipidaemia and 90 with metabolic syndrome. For data analysis, we used the Spearman correlation test adjusted according to Sidak between the dependent variable AHI and the independent variables BMI, ESS, average SO2 (SO(2med)), hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome. The results show different patterns of correlation in terms of statistical significance: BMI ρ(s) = 0.26, SO(2med) ρ(s) = -0:51, hypertension ρ(s) = -0.05, dyslipidaemia ρ(s) = 0.22 for women, and BMI ρ(s) = 0.53, ESS ρ(s) = 0.28, SO(2med) ρ(s) = -0.50, hypertension ρ(s) = 0.17, diabetes mellitus ρ(s) = 0.28 and metabolic syndrome ρ(s) = 0.26 for men. The results of the study confirm the existence of a statistically significant correlation between the severity of OSAS and BMI, ESS, average SO2, hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome. Pacini Editore SpA 2012-10 /pmc/articles/PMC3546405/ /pubmed/23326012 Text en © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Sleep Medicine
FUSETTI, M.
FIORETTI, A.B.
VALENTI, M.
MASEDU, F.
LAURIELLO, M.
PAGLIARELLA, M.
Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
title Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
title_full Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
title_fullStr Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
title_full_unstemmed Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
title_short Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
title_sort cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
topic Sleep Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546405/
https://www.ncbi.nlm.nih.gov/pubmed/23326012
work_keys_str_mv AT fusettim cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome
AT fiorettiab cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome
AT valentim cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome
AT maseduf cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome
AT lauriellom cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome
AT pagliarellam cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome